FDA approves Merck's Lipfendra — first cholesterol pill of its kind

The U.S. FDA has approved Merck's cholesterol pill Lipfendra, making it the first of its kind to receive regulatory clearance. Merck announced the decision on Thursday. The approval opens new treatment options for patients with high cholesterol levels.